
This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Columbia Banking (COLB) upgraded to Overweight from Neutral at Piper Sandler; tgt $32
> Dr. Reddy’s (RDY) upgraded to Buy from Neutral at BofA Securities
> SAP SE (SAP) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $143
Downgrades:
> Bath & Body Works (BBWI) downgraded to Hold from Buy at Argus
> First Republic Bank (FRC) downgraded to Neutral from Overweight at Argus
> Konami Holdings (KNMCY) downgraded to Underperform from Buy at CLSA
> Sage plc (SGPYY) downgraded to Neutral from Outperform at Exane BNP Paribas
> Xero (XROLF) downgraded to Outperform from Buy at CLSA
Others:
> Autolus Therapeutics (AUTL) initiated with a Buy at Bryan Garnier; tgt $5
> Cellectis (CLLS) initiated with a Buy at Bryan Garnier; tgt $6
> CRISPR Therapeutics (CRSP) initiated with a Buy at Bryan Garnier; tgt $70
> FactSet (FDS) initiated with an Outperform at CICC; tgt $500
Are You Ahead, or Behind on Retirement? (sponsor)
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: are you ahead, or behind on your retirement goals?
Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With SmartAsset’s free tool, you can connect with vetted financial advisors in minutes.
Why wait? Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.